Identification of CD105 (endoglin) as novel risk marker in CLL. Greiner SM, Marklin M, Holzmayer S, Kaban K, et al. Ann Hematol 2022;101:773-780.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Greiner SM, Marklin M, Holzmayer S, Kaban K, et al. Identification of CD105 (endoglin) as novel risk marker in CLL. Ann Hematol 2022;101:773-780.
PMID: 35044512